Diabetes.co.in
Dr. Rajesh Moganti

Dr. Rajesh Moganti

MBBS, MD (General Medicine), DM (Endocrinology)
Endocrinologist
8 years of experience

Education and Training

Andhra Medical College, Visakhapatnam
DM
Andhra Medical College, Visakhapatnam
2019 - Apr 2022
NRI Medical College, Guntur
MD
NRI Medical College, Guntur
Jun 2015 - Jun 2018
Rangaraya Medical College, Kakinada
MBBS
Rangaraya Medical College, Kakinada
2006 - 2012

Work Experience

Consultant Endocrinologist
Rajesh Diabetes and Endocrine Centre – Tanuku
2022
Consultant Endocrinologist
Rajesh Diabetes and Endocrine Centre – Rajamahendravaram
2022

Clinic Appointment

Rajesh Diabetes and Endocrine Centre (Rajahmundry)
Manasa Hospital Road, Rajamahendravaram, Andhra Pradesh, India, 533103
Rajesh Diabetes and Endocrine Centre (Tanuku)
Rastrapathi Road, Tanuku, Andhra Pradesh, India, 534211
About Dr. Rajesh Moganti

About

Dr. Rajesh Moganti, Physician and Endocrinologist, specializing in diabetes, endocrine and metabolic disorders.

Awards & Achievements

  • Co-Founder and Admin of Diabetes.co.in and Doctors.co.in Project.
  • Accomplished SEO Specialist specializing in the Health sector with two decades of expertise, catering to a diverse portfolio of corporate clients.
  • Endocrine Week 2020: Quiz winner
  • Passionate about SaaS for Health care, Health Care AI, and Health Tech and created multiple medical apps and websites.

Conferences and CME

  • Faculty – ESICON/ SAFES 2023 – Hyderabad – December 2023 “Digital therapeutics
  • Faculty - Yuvacrinology ESI - Hyderabad - August 2023 – “Endocrine Entrepreneurship

Memberships

  • Endocrine Society of India (ESI)
  • Indian Medical Association (IMA)

Services Provided

  • Type 2 Diabetes
  • Diabetes in Pregnancy
  • Thyroid Disorders
  • Hypertension in Young
  • PCOS/PCOD
  • Women Endocrinology
  • Obesity management
  • Gestational Diabetes Management
  • Diabetes in Children

Publications

  • Ramesh J, Reddy SS, Rajesh M, Varghese J. Evaluation of simple and cost-effective immuno-haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021 May 1; 15(3):739-45.
  • Ramesh J, Rajesh M, Varghese J, Reddy SS. Calculated plasma osmolality at hospital admission correlates well with eGFR and D-Dimer, a simple outcome predictor and guiding tool for management of severe COVID-19 patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021Sep1;15(5):102240).
  • Ramesh J, Varghese J, Reddy SLS, Rajesh M. Systemic inflammatory index a simple marker of thrombo-inflammation and prognosis in severe COVID-19 patients. Int J Adv Med 2021;8:1335-42.
  • Poster in Indian Thyroid Society Conference (ITSCON) 2020; Medullary and differentiated thyroid carcinoma as a collision tumor - A case report: Thyroid Research and Practice 17(1):p 43-50, Jan–Apr 2020. | DOI: 10.4103/0973-0354.283223
  • Poster presentation at Annual Conference of Endocrine society of India (ESICON), 2020 (Virtual); Can previous antidiabetic treatment influence outcome in hospitalized COVID-19 patients - A retrospective study
  • Poster presentation at 44th Andhra Pradesh State API annual Conference 2016: Case report of an young man with Devic’s disease
  • Poster presentation at APICON 2017, Mumbai. “Dengue fever associated Kinsborne Syndrome (Opsoclonus- myoclonus ataxia syndrome)”.

Book Chapters

  • Rajesh Moganti. Continuous glucose monitoring system. In: Kapoor D, editor. Diabetes in practice, vol. 1. First, Hyderabad, India: Paras publication; 2023.